MoonLake Immunotherapeutics (MLTX) Times Interest Earned (2022 - 2026)

MoonLake Immunotherapeutics' Times Interest Earned history runs 6 years deep, the most recent figure standing at -$30.45 for Q1 2026.

• In Q1 2026, Times Interest Earned rose 76.41% year-over-year to -$30.45; the TTM figure through Mar 2026 stood at -$33.2 (up 77.42% YoY), while the FY2025 annual figure was -$33.78, down 488.57% from the prior year.
• Times Interest Earned for Q1 2026 stood at -$30.45, down from -$29.81 in the prior quarter.
• The five-year high for Times Interest Earned was -$2.37 in Q2 2025, with the low at -$24265.3 in Q1 2022.
• The 5-year median for Times Interest Earned is -$86.9 (2023), against an average of -$1594.2.
• The sharpest annual moves came in 2022 and 2023: Times Interest Earned sank 5296.03% in 2022, then soared 98.63% in 2023.
• MoonLake Immunotherapeutics' Times Interest Earned stood at -$494.61 in 2022, then soared by 82.43% to -$86.9 in 2023, then slumped by 122.34% to -$193.21 in 2024, then soared by 84.57% to -$29.81 in 2025, then slipped by 2.14% to -$30.45 in 2026.
• Business Quant data shows MLTX's Times Interest Earned at -$30.45 in Q1 2026, -$29.81 in Q4 2025, and -$22.34 in Q3 2025.